Daré Bioscience, Inc. (DARE) Stock Forecast
Data as of May 10, 2026Healthcare · Current price $2.77 (-4.64%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
DARE vs Sector & Market
| Metric | DARE | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 19 |
| Target Upside | +332.4% | +1710.5% | +16.4% |
| P/E Ratio | -2.37 | 3.30 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $19M | $29M | $38M | 1 |
| 2027-12-31 | $65M | $65M | $65M | 2 |
| 2028-12-31 | $164M | $164M | $164M | 2 |
| 2029-12-31 | $185M | $275M | $364M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.33 | $-0.23 | $-0.13 | 1 |
| 2027-12-31 | $0.06 | $0.91 | $1.76 | 2 |
| 2028-12-31 | $1.86 | $4.09 | $6.33 | 2 |
| 2029-12-31 | $3.82 | $6.61 | $9.39 | 1 |
Frequently Asked Questions
What is the analyst consensus for DARE?
The consensus among 1 analysts covering Daré Bioscience, Inc. (DARE) is Buy with an average price target of $12.00.
What is the highest price target for DARE?
The highest analyst price target for DARE is $12.00.
What is the lowest price target for DARE?
The lowest analyst price target for DARE is $12.00.
How many analysts cover DARE?
1 analysts have issued ratings for Daré Bioscience, Inc. in the past 12 months.
Is DARE a buy or sell right now?
Based on 1 analyst ratings, DARE has a consensus rating of Buy (2.00/5) with a +332.4% upside to the consensus target of $12.00.
What are the earnings estimates for DARE?
Analysts estimate DARE will report EPS of $-0.23 for the period ending 2026-12-31, with revenue estimated at $29M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.